rss
J Clin Pathol 2005;58:1199-1205 doi:10.1136/jcp.2004.024786
  • Original article

Prognostic value of activated Akt expression in oral squamous cell carcinoma

  1. J Lim1,
  2. J-H Kim2,
  3. J-Y Paeng3,
  4. M-J Kim3,
  5. S-D Hong1,
  6. J-I Lee1,
  7. S-P Hong1
  1. 1Department of Oral Pathology, Dental School, Dental Research Institute, Seoul National University, 28-2 Yongon-dong, Jongno-gu, Seoul 110-744, Korea
  2. 2Department of Dentistry, Pundang Jesaeng Hospital, Pundang-gu, Kyounggi-do 463-774, Korea
  3. 3Department of Oral and Maxillofacial Surgery, Dental School, Seoul National University
  1. Correspondence to:
 Dr S-P Hong
 Department of Oral Pathology, Dental School, Dental Research Institute, Seoul National University, 28-2 Yongon-dong, Jongno-gu, Seoul 110-744, Korea; zjon0224snu.ac.kr
  • Accepted 9 March 2005

Abstract

Background: Akt is a serine/threonine kinase that plays an important role in tumorigenesis and influences prognosis in several cancers. However, its importance in oral squamous cell carcinomas (OSCC) has not been elucidated.

Aim: To investigate the association between the expression of activated Akt, clinicopathological factors, and E-cadherin, PCNA (proliferating cell nuclear antigen), and VEGF (vascular endothelial growth factor) expression to verify the validity of Akt as a prognostic factor in OSCC.

Methods: Phosphorylated Akt (p-Akt), E-cadherin, PCNA, and VEGF expression were assessed immunohistochemically in 84 OSCCs. The results were analysed in relation to clinicopathological factors.

Results: p-Akt was expressed in 29 cases. It was significantly correlated with lymph node metastasis, TNM stage, and E-cadherin expression. Univariate analysis showed that p-Akt expression, E-cadherin expression, PCNA expression, differentiation, tumour size, lymph node metastasis, TNM stage, and recurrence correlated with prognosis. Multivariate analysis showed that p-Akt expression is an independent prognostic factor in patients with OSCC.

Conclusions: This study revealed that Akt activation is a significant prognostic indicator for OSCC and is correlated with E-cadherin expression. The inhibition of Akt is a possible molecular approach to the treatment of OSCC.

Footnotes

    Register for free content


    Free trial
    Individuals may register for a free 60 day online trial to all content.

    Free archive
    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar